胶原纤维的组装和其他多聚结构
中文名称
通路描述
胶原三聚体以三螺旋形式存在,称为前胶原或胶原分子,从内质网出口并经过高尔基体网络运输,最终分泌到细胞外。对于纤维型胶原,即 I、II、III、V、XI、XXIV 和 XXVII 型(Gordon & Hahn 2010, Ricard-Blum 2011),分泌与 N 和 C 端前胶原肽的加工同时进行。这些加工后的分子称为原胶原,被认为是更高阶胶原结构的基本单元。它们通过一种可以自发进行的过程在细胞外空间形成,但在细胞环境中受到许多胶原结合蛋白的调节,如 FACIT(具有中断三螺旋的纤维关联胶原)家族胶原和小的富含亮氨酸蛋白聚糖(SLRPs)。最终形成的结构取决于胶原亚型和细胞条件。结构包括由主要结构胶原 I 和 II 形成的已知纤维和纤维,以及几种不同的超分子组装(Bruckner 2010)。组织的机械和物理性质取决于这些胶原含结构的空间排列和组成(Kadler et al. 1996, Shoulders & Raines 2009, Birk & Bruckner 2011)。
纤维型胶原结构经常是异质的,由一种主要胶原类型与较小量的其他类型结合组成,例如 I 型胶原纤维与 III 型和 V 型结合,而 II 型纤维经常包含 IX 型和 XI 型(Wess 2005)。由单一胶原类型组成的纤维可能不存在,因为 I 型和 II 型纤维分别需要 V 型和 XI 型胶原作为核子(Kadler et al. 2008, Wenstrup et al. 2011)。关于胶原纤维结构的大部分理解是通过纤维形成胶原,特别是 I 型胶原获得的,但一些中心特征被认为是至少适用于其他纤维型胶原亚型(Wess 2005)。纤维直径和长度因组织和胶原类型而异(Fang et al. 2012)。这些原因尚不清楚(Wess 2005)。
某些组织如皮肤具有直径相似的纤维,而某些组织如肌腱或软骨具有厚薄纤维的二模态分布。肌腱中成熟的 I 型胶原纤维长度可达 1 厘米,直径约为 500 纳米。单个纤维型胶原三螺旋直径小于 1.5 纳米,长度约为 300 纳米;胶原分子必须组装形成更高阶的纤维结构,这一过程称为纤维形成,由于 C 端前胶原肽的存在而被阻止(Kadler et al. 1987)。在电子显微镜下,纤维呈现带状外观,这是由于胶原分子重叠的规律性间隙,这是由于纤维以四分之一错位排列(Hodge & Petruska 1963)。胶原微纤维被认为具有准六边形单位细胞,原胶原排列形成超扭转的右旋微纤维,相互交织相邻微纤维,导致成熟胶原纤维具有螺旋状结构(Orgel et al. 2006, Holmes & Kadler 2006)。
相邻的原胶原单体相互相互作用,并通过赖氨酸氧化酶共价交联(Orgel et al. 2000, Maki 2006)。成熟的胶原纤维由赖氨酸氧化酶介导的交联稳定。羟赖氨酸吡啶啉和赖氨酸吡啶啉交联在骨和软骨中的(羟)赖氨酸和羟赖氨酸残基之间形成(Eyre et al. 1984)。Arginoline 交联可以在软骨中形成(Eyre et al. 2010);基于肽产物的成熟牛关节软骨含有等摩尔量的 Arginoline 和羟赖氨酸吡啶啉。成熟胶原纤维中的皮肤由赖氨酸氧化酶介导的交联羟丝氨酸 - 羟脯氨酸 - 羟脯氨酸(Yamauch et al. 1987)稳定。由于胶原分子在纤维中的四分之一错位排列,端肽通常与纤维中相邻胶原分子的三螺旋相互作用,除了那些以 4D 错位排列的另一个胶原分子的胶原分子。体外纤维聚集可以是单极或双极的,受温度和 C 蛋白酶水平的影响,表明 N 和 C 前肽在调节聚集过程中起作用(Kadler et al. 1996)。在体内,胶原分子在纤维表面可能保留其 N 前肽,表明这可能限制进一步的聚集,或者代表一个模型,其中纤维通过沉积、切割和进一步沉积的循环直径增长(Chapman 1989)。
在体内,纤维通常由一种或多种类型的胶原组成。III 型胶原与 I 型胶原在真皮纤维中结合,III 型胶原位于外周,表明具有调节作用(Fleischmajer et al. 1990)。V 型胶原与 I 型胶原纤维结合,其中它可能限制纤维直径(Birk et al. 1990, White et al. 1997)。IX 型与软骨和角膜中窄直径胶原 II 纤维的表面结合(Wu et al. 1992, Eyre et al. 2004)。高度特异性的交联位点模式表明胶原 IX 在纤维间网络中起作用(Wess 2005)。XII 型和 XIV 型胶原定位于带状胶原 I 纤维的表面(Nishiyama et al. 1994)。某些纤维关联胶原具有中断三螺旋(FACITs)与胶原纤维表面结合,其中它们可能限制纤维融合,从而调节纤维直径(Gordon & Hahn 2010)。胶原 XV,多肽素家族的一员,几乎 exclusively 与基膜附近的纤维型胶原网络结合。在人组织中,胶原 XV 将带状胶原纤维连接在基膜下方(Amenta et al. 2005)。XIV 型胶原、SLRPs 和盘状受体也调节纤维形成(Ansorge et al. 2009, Kalamajski et al. 2010, Flynn et al. 2010)。
胶原 IX 与胶原 II 纤维表面交联(Eyre et al. 1987)。XII 型和 XIV 型胶原与软骨中的 I 型(Walchli et al. 1994)和 II 型(Watt et al. 1992, Eyre 2002)纤维结合。它们被认为通过它们的 COL1/NC1 域非共价结合(Watt et al. 1992, Eyre 2002)。
某些非纤维型胶原形成与典型纤维不同的超分子组装。胶原 VII 形成锚定纤维,由反向平行的二聚体组成,连接真皮和表皮(Bruckner-Tuderman 2009)。在纤维形成过程中,新生 VII 型前胶原分子以反向平行方式二聚化。然后由骨形态发生蛋白 1(Rattenholl et al. 2002)去除 C 端前肽,随后形成的反向平行二聚体在侧向聚集。胶原 VIII 和 X 形成六边形网络,胶原 VI 形成串珠状丝(Gordon & Hahn 2010, Ricard-Blum et al. 2011)。
纤维型胶原结构经常是异质的,由一种主要胶原类型与较小量的其他类型结合组成,例如 I 型胶原纤维与 III 型和 V 型结合,而 II 型纤维经常包含 IX 型和 XI 型(Wess 2005)。由单一胶原类型组成的纤维可能不存在,因为 I 型和 II 型纤维分别需要 V 型和 XI 型胶原作为核子(Kadler et al. 2008, Wenstrup et al. 2011)。关于胶原纤维结构的大部分理解是通过纤维形成胶原,特别是 I 型胶原获得的,但一些中心特征被认为是至少适用于其他纤维型胶原亚型(Wess 2005)。纤维直径和长度因组织和胶原类型而异(Fang et al. 2012)。这些原因尚不清楚(Wess 2005)。
某些组织如皮肤具有直径相似的纤维,而某些组织如肌腱或软骨具有厚薄纤维的二模态分布。肌腱中成熟的 I 型胶原纤维长度可达 1 厘米,直径约为 500 纳米。单个纤维型胶原三螺旋直径小于 1.5 纳米,长度约为 300 纳米;胶原分子必须组装形成更高阶的纤维结构,这一过程称为纤维形成,由于 C 端前胶原肽的存在而被阻止(Kadler et al. 1987)。在电子显微镜下,纤维呈现带状外观,这是由于胶原分子重叠的规律性间隙,这是由于纤维以四分之一错位排列(Hodge & Petruska 1963)。胶原微纤维被认为具有准六边形单位细胞,原胶原排列形成超扭转的右旋微纤维,相互交织相邻微纤维,导致成熟胶原纤维具有螺旋状结构(Orgel et al. 2006, Holmes & Kadler 2006)。
相邻的原胶原单体相互相互作用,并通过赖氨酸氧化酶共价交联(Orgel et al. 2000, Maki 2006)。成熟的胶原纤维由赖氨酸氧化酶介导的交联稳定。羟赖氨酸吡啶啉和赖氨酸吡啶啉交联在骨和软骨中的(羟)赖氨酸和羟赖氨酸残基之间形成(Eyre et al. 1984)。Arginoline 交联可以在软骨中形成(Eyre et al. 2010);基于肽产物的成熟牛关节软骨含有等摩尔量的 Arginoline 和羟赖氨酸吡啶啉。成熟胶原纤维中的皮肤由赖氨酸氧化酶介导的交联羟丝氨酸 - 羟脯氨酸 - 羟脯氨酸(Yamauch et al. 1987)稳定。由于胶原分子在纤维中的四分之一错位排列,端肽通常与纤维中相邻胶原分子的三螺旋相互作用,除了那些以 4D 错位排列的另一个胶原分子的胶原分子。体外纤维聚集可以是单极或双极的,受温度和 C 蛋白酶水平的影响,表明 N 和 C 前肽在调节聚集过程中起作用(Kadler et al. 1996)。在体内,胶原分子在纤维表面可能保留其 N 前肽,表明这可能限制进一步的聚集,或者代表一个模型,其中纤维通过沉积、切割和进一步沉积的循环直径增长(Chapman 1989)。
在体内,纤维通常由一种或多种类型的胶原组成。III 型胶原与 I 型胶原在真皮纤维中结合,III 型胶原位于外周,表明具有调节作用(Fleischmajer et al. 1990)。V 型胶原与 I 型胶原纤维结合,其中它可能限制纤维直径(Birk et al. 1990, White et al. 1997)。IX 型与软骨和角膜中窄直径胶原 II 纤维的表面结合(Wu et al. 1992, Eyre et al. 2004)。高度特异性的交联位点模式表明胶原 IX 在纤维间网络中起作用(Wess 2005)。XII 型和 XIV 型胶原定位于带状胶原 I 纤维的表面(Nishiyama et al. 1994)。某些纤维关联胶原具有中断三螺旋(FACITs)与胶原纤维表面结合,其中它们可能限制纤维融合,从而调节纤维直径(Gordon & Hahn 2010)。胶原 XV,多肽素家族的一员,几乎 exclusively 与基膜附近的纤维型胶原网络结合。在人组织中,胶原 XV 将带状胶原纤维连接在基膜下方(Amenta et al. 2005)。XIV 型胶原、SLRPs 和盘状受体也调节纤维形成(Ansorge et al. 2009, Kalamajski et al. 2010, Flynn et al. 2010)。
胶原 IX 与胶原 II 纤维表面交联(Eyre et al. 1987)。XII 型和 XIV 型胶原与软骨中的 I 型(Walchli et al. 1994)和 II 型(Watt et al. 1992, Eyre 2002)纤维结合。它们被认为通过它们的 COL1/NC1 域非共价结合(Watt et al. 1992, Eyre 2002)。
某些非纤维型胶原形成与典型纤维不同的超分子组装。胶原 VII 形成锚定纤维,由反向平行的二聚体组成,连接真皮和表皮(Bruckner-Tuderman 2009)。在纤维形成过程中,新生 VII 型前胶原分子以反向平行方式二聚化。然后由骨形态发生蛋白 1(Rattenholl et al. 2002)去除 C 端前肽,随后形成的反向平行二聚体在侧向聚集。胶原 VIII 和 X 形成六边形网络,胶原 VI 形成串珠状丝(Gordon & Hahn 2010, Ricard-Blum et al. 2011)。
英文描述
Assembly of collagen fibrils and other multimeric structures Collagen trimers in triple-helical form, referred to as procollagen or collagen molecules, are exported from the ER and trafficked through the Golgi network before secretion into the extracellular space. For fibrillar collagens namely types I, II, III, V, XI, XXIV and XXVII (Gordon & Hahn 2010, Ricard-Blum 2011) secretion is concomitant with processing of the N and C terminal collagen propeptides. These processed molecules are known as tropocollagens, considered to be the units of higher order collagen structures. They form within the extracellular space via a process that can proceed spontaneously, but in the cellular environment is regulated by many collagen binding proteins such as the FACIT (Fibril Associated Collagens with Interrupted Triple helices) family collagens and Small Leucine-Rich Proteoglycans (SLRPs). The architecture formed ultimately depends on the collagen subtype and the cellular conditions. Structures include the well-known fibrils and fibres formed by the major structural collagens type I and II plus several different types of supramolecular assembly (Bruckner 2010). The mechanical and physical properties of tissues depend on the spatial arrangement and composition of these collagen-containing structures (Kadler et al. 1996, Shoulders & Raines 2009, Birk & Bruckner 2011).
Fibrillar collagen structures are frequently heterotypic, composed of a major collagen type in association with smaller amounts of other types, e.g. type I collagen fibrils are associated with types III and V, while type II fibrils frequently contain types IX and XI (Wess 2005). Fibres composed exclusively of a single collagen type probably do not exist, as type I and II fibrils require collagens V and XI respectively as nucleators (Kadler et al. 2008, Wenstrup et al. 2011). Much of the structural understanding of collagen fibrils has been obtained with fibril-forming collagens, particularly type I, but some central features are believed to apply to at least the other fibrillar collagen subtypes (Wess 2005). Fibril diameter and length varies considerably, depending on the tissue and collagen types (Fang et al. 2012). The reasons for this are poorly understood (Wess 2005).
Some tissues such as skin have fibres that are approximately the same diameter while others such as tendon or cartilage have a bimodal distribution of thick and thin fibrils. Mature type I collagen fibrils in tendon are up to 1 cm in length, with a diameter of approx. 500 nm. An individual fibrillar collagen triple helix is less than 1.5 nm in diameter and around 300 nm long; collagen molecules must assemble to give rise to the higher-order fibril structure, a process known as fibrillogenesis, prevented by the presence of C-terminal propeptides (Kadler et al. 1987). In electron micrographs, fibrils have a banded appearance, due to regular gaps where fewer collagen molecules overlap, which occur because the fibrils are aligned in a quarter-stagger arrangement (Hodge & Petruska 1963). Collagen microfibrils are believed to have a quasi-hexagonal unit cell, with tropocollagen arranged to form supertwisted, right-handed microfibrils that interdigitate with neighbouring microfibrils, leading to a spiral-like structure for the mature collagen fibril (Orgel et al. 2006, Holmes & Kadler 2006).
Neighbouring tropocollagen monomers interact with each other and are cross-linked covalently by lysyl oxidase (Orgel et al. 2000, Maki 2006). Mature collagen fibrils are stabilized by lysyl oxidase-mediated cross-links. Hydroxylysyl pyridinoline and lysyl pyridinoline cross-links form between (hydroxy) lysine and hydroxylysine residues in bone and cartilage (Eyre et al. 1984). Arginoline cross-links can form in cartilage (Eyre et al. 2010); mature bovine articular cartilage contains roughly equimolar amounts of arginoline and hydroxylysyl pyridinoline based on peptide yields. Mature collagen fibrils in skin are stabilized by the lysyl oxidase-mediated cross-link histidinohydroxylysinonorleucine (Yamauch et al. 1987). Due to the quarter-staggered arrangement of collagen molecules in a fibril, telopeptides most often interact with the triple helix of a neighbouring collagen molecule in the fibril, except for collagen molecules in register staggered by 4D from another collagen molecule. Fibril aggregation in vitro can be unipolar or bipolar, influenced by temperature and levels of C-proteinase, suggesting a role for the N- and C- propeptides in regulation of the aggregation process (Kadler et al. 1996). In vivo, collagen molecules at the fibril surface may retain their N-propeptides, suggesting that this may limit further accretion, or alternatively represents a transient stage in a model whereby fibrils grow in diameter through a cycle of deposition, cleavage and further deposition (Chapman 1989).
In vivo, fibrils are often composed from more than one type of collagen. Type III collagen is found associated with type I collagen in dermal fibrils, with the collagen III on the periphery, suggesting a regulatory role (Fleischmajer et al. 1990). Type V collagen associates with type I collagen fibrils, where it may limit fibril diameter (Birk et al. 1990, White et al. 1997). Type IX associates with the surface of narrow diameter collagen II fibrils in cartilage and the cornea (Wu et al. 1992, Eyre et al. 2004). Highly specific patterns of crosslinking sites suggest that collagen IX functions in interfibrillar networking (Wess 2005). Type XII and XIV collagens are localized near the surface of banded collagen I fibrils (Nishiyama et al. 1994). Certain fibril-associated collagens with interrupted triple helices (FACITs) associate with the surface of collagen fibrils, where they may serve to limit fibril fusion and thereby regulate fibril diameter (Gordon & Hahn 2010). Collagen XV, a member of the multiplexin family, is almost exclusively associated with the fibrillar collagen network, in very close proximity to the basement membrane. In human tissues collagen XV is seen linking banded collagen fibers subjacent to the basement membrane (Amenta et al. 2005). Type XIV collagen, SLRPs and discoidin domain receptors also regulate fibrillogenesis (Ansorge et al. 2009, Kalamajski et al. 2010, Flynn et al. 2010).
Collagen IX is cross-linked to the surface of collagen type II fibrils (Eyre et al. 1987). Type XII and XIV collagens are found in association with type I (Walchli et al. 1994) and type II (Watt et al. 1992, Eyre 2002) fibrils in cartilage. They are thought to associate non-covalently via their COL1/NC1 domains (Watt et al. 1992, Eyre 2002).
Some non-fibrillar collagens form supramolecular assemblies that are distinct from typical fibrils. Collagen VII forms anchoring fibrils, composed of antiparallel dimers that connect the dermis to the epidermis (Bruckner-Tuderman 2009). During fibrillogenesis, the nascent type VII procollagen molecules dimerize in an antiparallel manner. The C-propeptides are then removed by Bone morphogenetic protein 1 (Rattenholl et al. 2002) and the processed antiparallel dimers aggregate laterally. Collagens VIII and X form hexagonal networks and collagen VI forms beaded filament (Gordon & Hahn 2010, Ricard-Blum et al. 2011).
Fibrillar collagen structures are frequently heterotypic, composed of a major collagen type in association with smaller amounts of other types, e.g. type I collagen fibrils are associated with types III and V, while type II fibrils frequently contain types IX and XI (Wess 2005). Fibres composed exclusively of a single collagen type probably do not exist, as type I and II fibrils require collagens V and XI respectively as nucleators (Kadler et al. 2008, Wenstrup et al. 2011). Much of the structural understanding of collagen fibrils has been obtained with fibril-forming collagens, particularly type I, but some central features are believed to apply to at least the other fibrillar collagen subtypes (Wess 2005). Fibril diameter and length varies considerably, depending on the tissue and collagen types (Fang et al. 2012). The reasons for this are poorly understood (Wess 2005).
Some tissues such as skin have fibres that are approximately the same diameter while others such as tendon or cartilage have a bimodal distribution of thick and thin fibrils. Mature type I collagen fibrils in tendon are up to 1 cm in length, with a diameter of approx. 500 nm. An individual fibrillar collagen triple helix is less than 1.5 nm in diameter and around 300 nm long; collagen molecules must assemble to give rise to the higher-order fibril structure, a process known as fibrillogenesis, prevented by the presence of C-terminal propeptides (Kadler et al. 1987). In electron micrographs, fibrils have a banded appearance, due to regular gaps where fewer collagen molecules overlap, which occur because the fibrils are aligned in a quarter-stagger arrangement (Hodge & Petruska 1963). Collagen microfibrils are believed to have a quasi-hexagonal unit cell, with tropocollagen arranged to form supertwisted, right-handed microfibrils that interdigitate with neighbouring microfibrils, leading to a spiral-like structure for the mature collagen fibril (Orgel et al. 2006, Holmes & Kadler 2006).
Neighbouring tropocollagen monomers interact with each other and are cross-linked covalently by lysyl oxidase (Orgel et al. 2000, Maki 2006). Mature collagen fibrils are stabilized by lysyl oxidase-mediated cross-links. Hydroxylysyl pyridinoline and lysyl pyridinoline cross-links form between (hydroxy) lysine and hydroxylysine residues in bone and cartilage (Eyre et al. 1984). Arginoline cross-links can form in cartilage (Eyre et al. 2010); mature bovine articular cartilage contains roughly equimolar amounts of arginoline and hydroxylysyl pyridinoline based on peptide yields. Mature collagen fibrils in skin are stabilized by the lysyl oxidase-mediated cross-link histidinohydroxylysinonorleucine (Yamauch et al. 1987). Due to the quarter-staggered arrangement of collagen molecules in a fibril, telopeptides most often interact with the triple helix of a neighbouring collagen molecule in the fibril, except for collagen molecules in register staggered by 4D from another collagen molecule. Fibril aggregation in vitro can be unipolar or bipolar, influenced by temperature and levels of C-proteinase, suggesting a role for the N- and C- propeptides in regulation of the aggregation process (Kadler et al. 1996). In vivo, collagen molecules at the fibril surface may retain their N-propeptides, suggesting that this may limit further accretion, or alternatively represents a transient stage in a model whereby fibrils grow in diameter through a cycle of deposition, cleavage and further deposition (Chapman 1989).
In vivo, fibrils are often composed from more than one type of collagen. Type III collagen is found associated with type I collagen in dermal fibrils, with the collagen III on the periphery, suggesting a regulatory role (Fleischmajer et al. 1990). Type V collagen associates with type I collagen fibrils, where it may limit fibril diameter (Birk et al. 1990, White et al. 1997). Type IX associates with the surface of narrow diameter collagen II fibrils in cartilage and the cornea (Wu et al. 1992, Eyre et al. 2004). Highly specific patterns of crosslinking sites suggest that collagen IX functions in interfibrillar networking (Wess 2005). Type XII and XIV collagens are localized near the surface of banded collagen I fibrils (Nishiyama et al. 1994). Certain fibril-associated collagens with interrupted triple helices (FACITs) associate with the surface of collagen fibrils, where they may serve to limit fibril fusion and thereby regulate fibril diameter (Gordon & Hahn 2010). Collagen XV, a member of the multiplexin family, is almost exclusively associated with the fibrillar collagen network, in very close proximity to the basement membrane. In human tissues collagen XV is seen linking banded collagen fibers subjacent to the basement membrane (Amenta et al. 2005). Type XIV collagen, SLRPs and discoidin domain receptors also regulate fibrillogenesis (Ansorge et al. 2009, Kalamajski et al. 2010, Flynn et al. 2010).
Collagen IX is cross-linked to the surface of collagen type II fibrils (Eyre et al. 1987). Type XII and XIV collagens are found in association with type I (Walchli et al. 1994) and type II (Watt et al. 1992, Eyre 2002) fibrils in cartilage. They are thought to associate non-covalently via their COL1/NC1 domains (Watt et al. 1992, Eyre 2002).
Some non-fibrillar collagens form supramolecular assemblies that are distinct from typical fibrils. Collagen VII forms anchoring fibrils, composed of antiparallel dimers that connect the dermis to the epidermis (Bruckner-Tuderman 2009). During fibrillogenesis, the nascent type VII procollagen molecules dimerize in an antiparallel manner. The C-propeptides are then removed by Bone morphogenetic protein 1 (Rattenholl et al. 2002) and the processed antiparallel dimers aggregate laterally. Collagens VIII and X form hexagonal networks and collagen VI forms beaded filament (Gordon & Hahn 2010, Ricard-Blum et al. 2011).
所含基因
48 个基因
CD151
COL10A1
COL12A1
COL14A1
COL15A1
COL17A1
COL18A1
COL1A1
COL1A2
COL24A1
COL27A1
COL2A1
COL3A1
COL4A1
COL4A2
COL4A3
COL4A4
COL4A5
COL4A6
COL5A2
COL5A3
COL6A1
COL6A2
COL6A3
COL6A5
COL6A6
COL7A1
COL8A1
COL8A2
COL9A1
COL9A2
COL9A3
CTSB
CTSL
CTSL2
CTSS
DST
ITGA6
ITGB4
LAMA3
LAMB3
LAMC2
MMP13
MMP20
MMP3
MMP7
MMP9
PLEC